| INTRODUC TI ON
The lily family is composed of 280-300 genera made up of 4000-4600 different species but only 90 genera representing approximately 525 species are found in North America. Lilies are popular decorative plants and are also found in floral arrangements. The Convallaria genus, commonly called "lily of the valley," is used for decoration in the United States. 1 Lily of the valley usually grows in the cooler climate of North America and also in Europe and certain parts of Asia. The entire plant is toxic, containing cardiac glycosides causing digitalis-like toxicity. The principle toxic cardiac glycoside found in lily of the valley is convallatoxin. There are several reports of lily of the valley poisoning. 2 Symptoms of digitalis-like toxicity in a family after accidental ingestion of lily of the valley plant has also been reported. 3 Lethal poisoning of lily of the valley ingestion in a dog has also been reported. 4 Lily of the valley extract is used in herbal medicine despite known toxicity of the plant since the 16th century and is still used as a component in many herbal extracts as a tonic for heart. 5 Convallatoxin, the major cardiac glycoside present in lily of the valley, has digitalis-like properties by inhibition of the Na, K-ATPase thereby causing a positive inotropic effect. 6 Convallatoxin has structural similarity with digoxin, and we reported earlier rapid detection of convallatoxin in human serum using luminescent oxygen channeling technology-based digoxin
Objective: Lily of the valley is a poisonous plant due to the presence of the cardiac glycoside convallatoxin which is known to interfere with serum digoxin measurement using the LOCI digoxin assay and other digoxin assays. We evaluated potential interference of convallatoxin as well as extract of lily of the valley with the ADVIA Centaur digoxin assay by comparing results obtained using the LOCI digoxin assay.
Materials and Methods:
Aliquots of a drug-free serum pool and a digoxin serum pool were supplemented with nanograms to 1 μg quantities of convallatoxin or 1.0 and 2.5 μL of lily of the valley extract per milliliter of serum followed by measurement of digoxin concentrations using the LOCI and ADVIA Centaur digoxin assays.
Results: Apparent digoxin concentrations were minimal using the ADVIA Centaur digoxin assay when aliquots of drug-free serum were supplemented with convallatoxin or extract of lily of the valley but apparent digoxin levels were very high using the LOCI digoxin assay. Moreover, minimal interference in serum digoxin measurement using the ADVIA Centaur digoxin assay was observed when aliquots of serum digoxin pool were further supplemented with lily of the valley extract. As expected, the LOCI digoxin assay showed significant interference of convallatoxin in serum digoxin measurement.
Conclusions: Significant interference of convallatoxin in serum digoxin measurement using the LOCI digoxin assay could be minimized using the ADVIA Centaur digoxin assay.
K E Y W O R D S
ADVIA Centaur digoxin assay, convallatoxin, lily of the valley, LOCI digoxin assay assay (LOCI Digoxin assay). 7 More recently, we reported that the iDigoxin assay on the Architect i1000 analyzer marketed by Abbott
Laboratories is more sensitive than the LOCI digoxin assay in detecting the presence of convallatoxin. 8 Recently, in our laboratory, ADVIA Centaur digoxin assay is available. We compared interference of convallatoxin with the ADVIA Centaur digoxin assay by comparing results obtained using the LOCI digoxin assay. The potential interference of convallatoxin in the ADVIA Centaur digoxin assay has never been reported before.
| MATERIAL S AND ME THODS
Convallatoxin was purchased from the Sigma Chemical Company Statistical analyses were performed using the two-tailed student t test. A statistically significant difference was considered at 95% confidence interval or higher (P < .05).
| RE SULTS
Significant apparent digoxin concentrations were observed when aliquots of drug-free serum pool were supplemented with either convallatoxin or liquid extract of lily of the valley and the LOCI digoxin assay was used for measurement. In contrast, observed apparent digoxin concentrations were relatively low using the ADVIA Centaur digoxin assay. For example, no apparent digoxin concentration was observed when aliquots of drug-free serum pool were supplemented with up to 100 ng of convallatoxin per milliliter of serum. In contrast, the observed apparent digoxin concentration was 1.08 ng mL −1 using the LOCI digoxin assay. Although measurable apparent digoxin levels (>.1 ng mL −1 ) were observed when aliquots of the drug-free serum pool were supplemented with higher concentration of convallatoxin or lily of the valley extract, observed apparent digoxin levels were relatively low using the ADVIA Centaur digoxin assay. For example, highest apparent digoxin concentration of .24 ng mL −1 was observed using the ADVIA Centaur digoxin assay when an aliquot of the drugfree serum pool was supplemented with lily of the valley extract to achieve a final concentration of 2.5 μL of extract per milliliter of serum, the corresponding apparent digoxin value was 5.85 ng mL −1 using the LOCI digoxin assay (Table 1) .
Because cross-reactivity of a substance should be tested in the presence of the primary analyte, 10 convallatoxin or lily of the valley extract to aliquots of a digoxin pool to test cross reactivity of convallatoxin in the presence of the primary analyte digoxin was also investigated. Bi-directional (negative interference with smaller amounts of convallatoxin but positive interference with higher amounts of convallatoxin) interference of convallatoxin with serum digoxin measurement using the LOCI digoxin assay was observed. This observation is consistent with our previous report. 7 However, the ADVIA Centaur digoxin showed very little interference in serum digoxin measurement in the presence of convallatoxin or lily of the valley extract.
We observed no statistically significant change in digoxin values when aliquots of digoxin pool were supplemented with convallatoxin. For example, in the presence of 1000 ng mL −1 of convallatoxin, the serum digoxin concentration was 0.99 ng mL −1 which was not statistically different from the baseline digoxin value of 1.05 ng mL −1 . In contrast, when the digoxin concentration was measured using the LOCI digoxin assay, the value was 4.37 ng mL −1 (baseline value was 1.01 ng mL −1 ). However, in the presence of 2.5 μL of lily of the valley extract per milliliter of digoxin pool, the digoxin value was increased to 1.17 ng mL −1 , a value significantly higher than baseline value of 1.05 ng mL −1 by independent t test two tailed, but the increase in digoxin value was only 11.4%.
In contrast, the observed digoxin concentration was 6.05 ng mL
using the LOCI digoxin assay, a fivefold increase from the baseline value (Table 2 ).
In general, bias over 20% (positive or negative) is considered clinically significant according to the criterion defined by the College of American Pathologists. Therefore, interference observed in the digoxin assay using the ADVIA Centaur assay may not be clinically significant.
| D ISCUSS I ON
Accidental poisoning by lily of the valley in both animals and humans has been reported. In addition, it is possible that a person taking digoxin may also take lily of the valley herbal supplement due to increased and widespread use of herbal remedies. Dietary supplement is approximately $30 billion industry in the United States and based on recent surveys, 52% adults reported use of at least 1 supplement and 10% reported using at least 4 products. 11 Lily of the valley extract is available in health food store without prescription.
Convallatoxin can only be analyzed using chromatographic methods. However, the bigger problem is when a person taking digoxin may also take lily of the valley extract because this herbal supplement is marketed as a heart tonic. Digoxin is a cardiac glycoside with a narrow therapeutic range. Therefore, it is important to accurately measure serum digoxin level in patients taking digoxin.
Immunoassays are widely used for digoxin measurement in clinical laboratories but digoxin assays also suffer from various interferences. 13 
